- Home
- TWIN vs FENC Comparison
TWIN vs FENC Comparison
Compare TWIN & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TWIN | FENC |
|---|---|---|
| Founded | 1918 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 276.2M | 276.3M |
| IPO Year | N/A | 2001 |
Fundamental Metrics
Financial Performance| Metric | TWIN | FENC |
|---|---|---|
| Price | $17.51 | $7.68 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $12.00 | ★ $15.00 |
| AVG Volume (30 Days) | 32.3K | ★ 173.0K |
| Earning Date | 02-04-2026 | 03-09-2026 |
| Dividend Yield | ★ 0.91% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $347,837,000.00 | $38,790,000.00 |
| Revenue This Year | $10.79 | N/A |
| Revenue Next Year | $8.43 | $70.78 |
| P/E Ratio | $713.29 | ★ N/A |
| Revenue Growth | ★ 14.24 | N/A |
| 52 Week Low | $6.16 | $4.68 |
| 52 Week High | $19.33 | $9.92 |
Technical Indicators
Market Signals| Indicator | TWIN | FENC |
|---|---|---|
| Relative Strength Index (RSI) | 52.35 | 51.19 |
| Support Level | $17.39 | $7.35 |
| Resistance Level | $18.97 | $7.84 |
| Average True Range (ATR) | 0.76 | 0.32 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 49.52 | 47.37 |
Price Performance
Historical ComparisonAbout TWIN Twin Disc Incorporated
Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.